GBSN

geben. Das kann sich jetzt erstmal gut erholen

mMn  

Vorteil das mit höheren Kursen die zu wandelten Stücke aus den Warrants immer weniger werden, die benötigt werden und die Warrathalter können somit schneller ihr Geld wieder bekommen.  

 

bevor wieder alles weg ist.  

 

was hast du mit dem Teufel GBSN zu tun :-)))  

wenn das mal keiner Fehler war :-))))



Nicht das der teure An- und Verkauf bei den Amis zu viel frisst .



 

 

das war lediglich nur ein kleiner Scherz :-))))  

börsen-spiel  

 

derzeit schon ok. Denke da an die FDA Zulassungen zurück - da lag die MK im Bereich 20-25 Mio.

Man korrigiere mich  

Was will uns der Verfasser damit sagen?!!!!! :-) Was ist damit möglich!!!!

 As disclosed in Item 1.01 of the Current Report on Form 8-K of Great Basin Scientific, Inc. (the “Company”), dated December 28, 2015, the Company has previously entered into a Securities Purchase Agreement, dated December 28, 2015 (the “Securities Purchase Agreement”) with certain investors named on the Schedule of Buyers attached to the Securities Purchase Agreement (each a “Buyer”), pursuant to which the Company issued to such Buyers $22.1 million in principal face amount of senior secured convertible notes of the Company (the “Notes”) and related Series D common stock purchase warrants. As of September 30, 2016, approximately $14.1 million in principal face amount of Notes remains outstanding.

On October 2, 2016, Great Basin Scientific, Inc. (the “Company”) entered into separate exchange agreements (each, an “Exchange Agreement”) with each of the Buyers, pursuant to which, among other things each of the parties thereto agreed to the following:

 
    (i)     If any Notes remain outstanding on November 18, 2016 (the “Exchange Date”), on the Exchange Date all such remaining Notes shall be exchanged into shares of our common stock (or, if necessary to comply with the restrictions on beneficial ownership set forth in the Exchange Agreement, a combination of shares of our common stock and rights to acquire shares of our common stock without the payment of any additional consideration) at an exchange price equal to 85% of the lowest daily weighted average price of our common stock during the five (5) consecutive trading days ending and including the trading day immediately prior to the Exchange Date (the “Exchange”);

 
    (ii)     During the period from October 3, 2016 through November 17, 2016, pursuant to Section 7(d) of the Notes, the Company will permit each Buyer to convert the Notes at an alternate conversion price equal to 85% of the lowest daily weighted average price of our common stock during the five (5) consecutive trading days ending and including the date of conversion (each, a “Voluntary Reduction”);

 
    (iii)     The Buyers released all restrictions on the Company’s use of approximately $3.5 million of proceeds of the offering of Notes and, subject to the satisfaction of certain customary conditions, including that the daily dollar trading volume of our common stock during the twenty trading days immediately prior to November 1, 2016 is at least $100,000 per trading day, on November 1, 2016 the Buyers will release all restrictions on the Company’s use of the remaining approximately $3.6 million of proceeds of the offering of our Notes;

 
    (iv)     Each of the Buyers agreed to waive various economic antidilution adjustments that would have otherwise occurred as a result of such Voluntary Reductions to certain other securities issued by the Company and held by such Buyers; and

 
    (v)     Each of the Buyers agreed that, while the Note will continue to amortize in accordance with the terms of the Note in October 2016, any amortization to occur in November 2016 will be deferred in accordance with the terms of the Notes until December 2016 unless exchanged or converted in full prior to such date.

 
    (vi)     The Leak-Out Agreements, each by and between a Buyer and the Company, shall be amended by increasing the aggregate leak-out percentage from 35% to 40% of our common stock’s daily trading volume and removing any leak-out restrictions during the period commencing on October 17, 2016 and ending and including October 21, 2016.

The Exchange is subject to customary closing conditions, including without limitation that no unwaived event of default under the Notes exists and is continuing and that the arithmetic average of the daily dollar trading volume of our common stock during the twenty trading days prior to the Exchange is at least $300,000.

After giving effect to such Exchange, all rights and obligations under the Notes shall be cancelled.

The foregoing is a summary description of the material terms of the Exchange Agreements and is qualified in its entirety by the text of the form of Exchange Agreement attached as Exhibit 10.1 to this Current Report on Form 8-K and incorporated by reference to this Item 1.01.

http://secfilings.nasdaq.com/...20INC.&FormType=8-K&View=html

 

 

 

                              §  

Was uns der Verfasser sagen?  

wieder bei 50 Cent....so enfach wäre das und zeitgleich sind die Warrants durch und kein Verkaufsdruck mehr. Danach eine gute NEWS und man sieht die 2-3 Dollar wieder....

....Ach.... Seufz....ein schönes Träumchen ;-)  

das der Rebound vorbei ist .


0,04 = 25 %, ist Okay .  

(iii)     The Buyers released all restrictions on the Company’s use of approximately $3.5 million of proceeds of the offering of Notes and, subject to the satisfaction of certain customary conditions, including that the daily dollar trading volume of our common stock during the twenty trading days immediately prior to November 1, 2016 is at least $100,000 per trading day, on November 1, 2016 the Buyers will release all restrictions on the Company’s use of the remaining approximately $3.6 million of proceeds of the offering of our Notes;

 (vi)     The Leak-Out Agreements, each by and between a Buyer and the Company, shall be amended by increasing the aggregate leak-out percentage from 35% to 40% of our common stock’s daily trading volume and removing any leak-out restrictions during the period commencing on October 17, 2016 and ending and including October 21, 2016.

The Exchange is subject to customary closing conditions, including without limitation that no unwaived event of default under the Notes exists and is continuing and that the arithmetic average of the daily dollar trading volume of our common stock during the twenty trading days prior to the Exchange is at least $300,000.

(i)     If any Notes remain outstanding on November 18, 2016 (the “Exchange Date”)

Wie war das MK wird weniger beim 50% Abverkauf!

Wie können die 300000 dann gehalten werden?

Denke das ist das Ende der Dilu.

Aber!!!!!!

(i)     If any Notes remain outstanding on November 18, 2016 (the “Exchange Date”), on the Exchange Date all such remaining Notes shall be exchanged into shares of our common stock (or, if necessary to comply with the restrictions on beneficial ownership set forth in the Exchange Agreement, a combination of shares of our common stock and rights to acquire shares of our common stock without the payment of any additional consideration) at an exchange price equal to 85% of the lowest daily weighted average price of our common stock during the five (5) consecutive trading days ending and including the trading day immediately prior to the Exchange Date (the “Exchange”);

Ich lese aus dem Schmodder das es steigen wird und die 5 Handelstage vor der Wandlung wird noch mal draufgeklopft.

Aber wie gesagt, würde nicht drauf wetten!!!!!!!

 

Man meint ja man hat eine Tüte Collorado vor sich ""da ist für jeden was dabei"" aber wo ist Ray !???? .... tja, das weiß niemand so Recht ;-)  

GBSN Aktionäre  

extrem selten in den letzten Jahren.

MK ausgehend von 45 Mio Aktien bei 1,8 Mio

Das ganze ausgestattet mit 2 FDA Zulassungen

Da kenne ich Unternehme die keine FDA Zulassung haben und
mit mehreren Millionen bewertet sind.  

leider nur sehr grauenvoll. Wir müssen bis 15:30 abwarten  

15:30 uhr  0,111  ???????????????